TMEM52B and nonpapillary renal cell carcinoma: To determine whether genetic alterations contribute to the silencing of C12orf59, we performed sequence screening on the exons and exon-intron junctions of C12orf59 in 5 renal cancer cell lines and 100 paired ccRCC samples using PCR and direct sequencing.